跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
欧唐宁 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Linagliptin Tablets
Approved
化学药品
Linagliptin Tablets
Boehringer Ingelheim International GmbH
🇨🇳 National Medical Products Administration
Approval Date
Nov 22, 2021
Approval ID
8DqcE901yNQ
Company
Boehringer Ingelheim International GmbH
Type
化学药品
Approval Details
Approval Id
8DqcE901yNQ
Approval Number
国药准字HJ20171166
Generic Name
利格列汀片
Generic Name En
Linagliptin Tablets
Trade Name
欧唐宁
Drug Type
化学药品
Dosage Form
片剂
Strength
5mg
Reg Date
2021-11-22
Expired Date
2026-11-21
Company Name
Boehringer Ingelheim International GmbH
Production Company Name
WEST WARD COLUMBUS INC
Company Detail Path
/organization/boehringer-ingelheim-international-gmbh
Production Company Detail Path
/organization/west-ward-columbus-inc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Nov 22, 2021
Approval ID
8DqcE901yNQ
Type
化学药品
Back to NMPA Approvals